Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive Impairment
Clinical trial NCT07711171 · RECRUITING
Trial details
- NCT number
- NCT07711171
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-19
- Primary completion
- 2026-10-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.